HTEC logo

ROBO Global Healthcare Technology and Innovation ETF (HTEC)

$42.62

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HTEC

AUM

$105485438

P/E ratio

28.8

Dividend yield

0.746%

Expense ratio

0.68%

Beta

1.056849

Price on HTEC

Previous close

$43.10

Today's open

$43.02

Day's range

$42.50 - $43.19

52 week range

$31.84 - $47.25

Profile about HTEC

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

HTEC industries and sectors

Industries

Health

News on HTEC

Webcast: What M&A Trends Say About AI, Robotics & More

Just because rates have risen and borrowing is a bit more challenging doesn't mean M&A has stopped. Far from it, as major deals continue to help define key categories from robotics to AI and plenty in between.

news source

ETF Trends • Nov 12, 2026

news preview

Post-Election Outlook for Health Innovation

The U.S. midterm elections left Democrats in control of both chambers. This has sparked an immediate rally for hospitals and insurers, while innovative health tech moved sharply the other way.

news source

ETF Trends • Nov 11, 2026

news preview

3 Reasons HTEC Stands Out Among the Best Health Tech ETFs

Every day, headlines extoll the potential in AI investing, and the markets reflect that; the biggest companies in the S&P 500 include the key AI hyperscalers. Still, the impact of AI will be much deeper and more widespread than that — especially in other tech-heavy segments.

news source

ETF Trends • Nov 5, 2026

news preview

Who's Buying the Future of AI & Robotics: 2026 M&A Report

After several years of cooling appetite for M&A and large IPOs, 2026 has seen a resurgence in both, as well as increased appetite for venture fundraising in robotics and physical AI.

news source

ETF Trends • Nov 4, 2026

news preview

How Tempus AI Built a Defensible Data Moat in Precision Healthcare

As access to powerful general-purpose AI models expands, access alone offers limited differentiation. In precision healthcare, competitive advantage can come from combining proprietary clinical data, specialized models, and integration into diagnostic workflows.

news source

ETF Trends • Oct 22, 2026

news preview

How to Invest in AI Drug Discovery

.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.

news source

ETF Trends • Oct 14, 2026

news preview

How Healthcare Tech ETF HTEC Defied September's Market Turmoil

It's always exciting to see a fund perform well over the course of a month, but it's also important to understand exactly why that strong performance may be happening. Key Takeaways: September proved to be a relatively difficult month for many sectors of the equity market, including the healthcare sector.

news source

ETF Trends • Oct 5, 2026

news preview

The Top HealthTech Questions Landing on Our Desks

Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).

news source

ETF Trends • Sep 30, 2026

news preview

AI & Robotics in 2026: 16 Recent Developments for Investors

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper inference, AI systems reaching into laboratories and physical equipment, robots learning from fewer demonstrations, and new capital and infrastructure forming around commercial deployment.

news source

ETF Trends • Sep 9, 2026

news preview

Why Moderna's Cancer Vaccine Matters to Investors

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.

news source

ETF Trends • Sep 2, 2026

news preview

¹ Disclosures

Get started with M1

Invest in ROBO Global Healthcare Technology and Innovation ETF

Open an M1 investment account to buy and sell ROBO Global Healthcare Technology and Innovation ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HTEC on M1